How are Triamterene And Hydrochlorothiazide adverse event reports trending over time?
This graph shows volume of adverse events submitted to the FDA by quarter for Triamterene And Hydrochlorothiazide, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Triamterene And Hydrochlorothiazide is flagged as the suspect drug causing the adverse event.
What are the most common Triamterene And Hydrochlorothiazide adverse events reported to the FDA?
Completed Suicide | 52 (3.28%) |
Dizziness | 48 (3.02%) |
Hyponatraemia | 32 (2.02%) |
Renal Failure Acute | 32 (2.02%) |
Dyspnoea | 27 (1.7%) |
Drug Ineffective | 26 (1.64%) |
Muscle Spasms | 23 (1.45%) |
Asthenia | 21 (1.32%) |
Pulmonary Embolism | 20 (1.26%) |
Hypotension | 19 (1.2%) |
Nausea | 19 (1.2%) |
Show More |
Share/Embed Graph Export Data
This graph shows the top adverse events submitted to the FDA for Triamterene And Hydrochlorothiazide, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Triamterene And Hydrochlorothiazide is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
What are the most common Triamterene And Hydrochlorothiazide adverse events reported to the FDA?
Neurological | 102 (6.43%) |
Electrolyte And Fluid Balance Condi... | 89 (5.61%) |
Epidermal And Dermal Conditions | 76 (4.79%) |
Respiratory | 61 (3.84%) |
Gastrointestinal Signs | 60 (3.78%) |
Therapeutic And Nontherapeutic Effe... | 57 (3.59%) |
Suicidal And Self-injurious Behavio... | 55 (3.47%) |
Cardiac Arrhythmias | 46 (2.9%) |
Renal Disorders | 44 (2.77%) |
Cardiac And Vascular Investigations | 43 (2.71%) |
Muscle | 41 (2.58%) |
Show More |
Share/Embed Graph Export Data
This graph shows the top categories of adverse events submitted to the FDA for Triamterene And Hydrochlorothiazide, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Triamterene And Hydrochlorothiazide is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
Why are people taking Triamterene And Hydrochlorothiazide, according to those reporting adverse events to the FDA?
Hypertension | 613 |
Product Used For Unknown Indication | 185 |
Drug Use For Unknown Indication | 166 |
Blood Pressure | 71 |
Diuretic Therapy | 52 |
Fluid Retention | 48 |
Show More |
Label | Labeler | Effective |
---|---|---|
Triamterene And Hydrochlorothiazide | Mylan Pharmaceuticals Inc. | 06-FEB-02 |
Triamterene Hydrochlorothiazide | KAISER FOUNDATION HOSPITALS | 17-FEB-10 |
Triamterene And Hydrochlorothiazide | State of Florida DOH Central Pharmacy | 21-MAY-10 |
Triamterene And Hydrochlorothiazide | State of Florida DOH Central Pharmacy | 21-MAY-10 |
Triamterene And Hydrochlorothiazide | State of Florida DOH Central Pharmacy | 07-JUN-10 |
Triamterene And Hydrochlorothiazide Capsules | UDL Laboratories, Inc. | 12-NOV-10 |
Triamterene And Hydrochlorothiazide | REMEDYREPACK INC. | 17-NOV-10 |
Triamterene And Hydrochlorothiazide | Rebel Distributors Corp | 01-DEC-10 |
Triamterene Hydrochlorothiazide | Rebel Distributors Corp | 01-DEC-10 |
Dyazide | Cardinal Health | 04-JAN-11 |
Triamterene And Hydrochlorothiazide | Mylan Pharmaceuticals Inc. | 19-JAN-11 |
Triamterene And Hydrochlorothiazide | PD-Rx Pharmaceuticals, Inc. | 19-JAN-11 |
Triamterene And Hydrochlorothiazide | PD-Rx Pharmaceuticals, Inc. | 16-FEB-11 |
Triamterene And Hydrochlorothiazide | PD-Rx Pharmaceuticals, Inc. | 16-FEB-11 |
Triamterene And Hydrochlorothiazide | UDL Laboratories, Inc. | 10-JUN-11 |
Triamterene And Hydrochlorothiazide | Apotex Corp. | 06-OCT-11 |
Triamterene And Hydrochlorothiazide | REMEDYREPACK INC. | 24-OCT-11 |
Triamterene And Hydrochlorothiazide | REMEDYREPACK INC. | 02-NOV-11 |
Dyazide | GlaxoSmithKline LLC | 20-JAN-12 |
Triamterene And Hydrochlorothiazide | PD-Rx Pharmaceuticals, Inc. | 25-JAN-12 |
Triamterene And Hydrochlorothiazide | Sandoz Inc | 25-JAN-12 |
Triamterene Hydrochlorothiazide | Physicians Total Care, Inc. | 03-FEB-12 |
Triamterene And Hydrochlorothiazide | REMEDYREPACK INC. | 07-MAR-12 |
Triamterene Hydrochlorothiazide | Sandoz Inc | 23-APR-12 |
Triamterene Hydrochlorothiazide | PD-Rx Pharmaceuticals, Inc. | 23-APR-12 |
Triamterene And Hydrochlorothiazide | Preferred Pharmaceuticals, Inc | 30-APR-12 |
Triamterene And Hydrochlorothiazide | Preferred Pharmaceuticals, Inc | 30-APR-12 |
Triamterene And Hydrochlorothiazide | Watson Laboratories, Inc. | 30-APR-12 |
Triamterene And Hydrochlorothiazide | Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC | 31-MAY-12 |
Triamterene And Hydrochlorothiazide | Physicians Total Care, Inc. | 15-JUN-12 |
Triamterene And Hydrochlorothiazide | AvKARE, Inc. | 03-JUL-12 |
Triamterene And Hydrochlorothiazide | Lannett Company, Inc. | 12-JUL-12 |
Triamterene And Hydrochlorothiazide | Barr Laboratories Inc. | 14-SEP-12 |
Triamterene And Hydrochlorothiazide | STAT Rx USA LLC | 25-SEP-12 |
Triamterene And Hydrochlorothiazide | Bryant Ranch Prepack | 12-OCT-12 |
Triamterene Hydrochlorothiazide | NCS HealthCare of KY, Inc dba Vangard Labs | 15-NOV-12 |
Triamterene And Hydrochlorothiazide | NCS HealthCare of KY, Inc dba Vangard Labs | 15-NOV-12 |
Triamterene And Hydrochlorothiazide | KAISER FOUNDATION HOSPITALS | 17-JAN-13 |
Triamterene And Hydrochlorothiazide | Bryant Ranch Prepack | 17-JAN-13 |
Triamterene Hydrochlorothiazide | Bryant Ranch Prepack | 17-JAN-13 |
Triamterene And Hydrochlorothiazide | Bryant Ranch Prepack | 17-JAN-13 |
What Triamterene And Hydrochlorothiazide safety concerns are being reported by doctors and researchers in the medical literature?
This report contains aggregated drug side effects and adverse events for Triamterene And Hydrochlorothiazide. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.
DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.
DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.
Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.
Share your experience with Triamterene And Hydrochlorothiazide.